Abstract
To assess the spread of human T-cell leukemia virus (HTLV) type I and II in different population groups at potential risk of infection in Spain, a total of 756 subjects were studied: 453 belonging to groups at risk for retrovirus infection, 255 with diseases potentially linked to HTLV-I/II infection and 48 immigrants from endemic areas. An HTLV-I viral-lysate enzyme immunoassay (EIA) with a recombinant transmembrane envelope protein incorporated was used to screen serum samples. Reactive specimens were confirmed by Western blot strips spiked with recombinant proteins that differentiated HTLV-I from HTLV-II. Infection was then verified by the polymerase chain reaction (PCR). Serum samples from 19 of the 756 subjects analyzed (2.5 %) were reactive for HTLV by EIA. One of these was from an intravenous drug user (IVDU) in whom HTLV-II infection was confirmed by Western blot and PCR; a specimen from another IVDU showed Western blot reactivity for both retroviruses, but PCR results were negative. Lastly, Western blot confirmed the presence of HTLV in one of the immigrant subjects. Western blot did not verify HTLV infection in the remaining 16 cases, indicating a high rate of nonspecific anti-HTLV reactivity when a second-generation EIA screening test was applied. These results suggest that HTLV is present in Spain among populations at high risk for HTLV, although at a very low rate and restricted to intravenous drug users and individuals immigrating from endemic areas.
Similar content being viewed by others
References
Soriano V, Gutiérrez M, Tuset C, Calderón E: EI HTLV-I. Revista Clinica Española 1994, 194: 551–557.
Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992, 339: 645–646.
Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shawn GM, Blattner WA: Endemic human T-cell lym-photropic virus type II infection among isolated Brazilian Amerindians. Journal of Infectious Diseases 1992, 166: 100–107.
Coste J, Lemaire JM, Couroucé AM, Caravaggio M, the Retrovirus Study Group of the French Society of Blood Transfusion: Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. AIDS 1993, 7: 440–441.
Castillo MJ, Sánchez-Román J, Varela JM, Andreu J, Gavilán F, Fernández-Cruz J, Barea JL: Granulomatosis linfomatoidea: análisis clinicopatológico de 7 casos. Medicina Clínica 1992, 98: 540–542.
Soriano V, Tor J, Monzon M, Graus JM, Clotet B, Ribas-Mundo M: HTLV-I in Spain. Lancet 1990, 336: 627–628.
Soriano V, Calderón E, Esparza B, Cilla G, Aguilera A, Gutiérrez M, Tor J, Pujol E, Merino F, Pérez-Trallero, Leal M, González-Lahoz J, the Spanish Study Group: HTLV-I/II infections in Spain. International Journal of Epidemiology 1993, 22: 716–719.
Calderón EJ, Gómez-Lucia E, Aguado I, Pineda JA, Essex M, Leal M: Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 773–775.
Calderón E, Medrano J, Rey C, Leal M: Infección por HTLV-I/II en Andalucía. In: Pujol de la Llave E (ed): Infecciones humanas por retrovirus. Gráficas Dialar, Málaga, 1992, p. 15–30.
Pujol E, Ollero M, Márquez P, Gea A, Alcoucer R, Gimeno A: Infección por HTLV-I en marineras que viajan al Africa occidental subsahariana. Enfermedades Infecciosas y Microbiología Clínica 1991, 9: 283–285.
Soriano V, Calderön E, Gutiérrez M, Tuset R, Martinez-Zapico R, González-Lahoz J, the HTLV-I/II Spanish Group: Misdiagnosis of HTLV-II infection using HTLV-I screening assays. AIDS 1993, 7: 1395.
Kwok S, Kellogg DE, Ehrlich G, Poiesz B, Bhagavatis S, Sninsky JJ: Characterization of a sequence of human T-cell leukemia virus type I from a patient with chronic progressive myelopathy. Journal of Infectious Diseases 1988, 158: 1193–1197.
Wiktor SZ, Piot P, Mann JM, Nzilambi N, Francis H, Vercauteren G, Blattner WA, Quinn TC: Human T cell leukemia virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. Journal of Infectious Diseases 1990, 161: 1073–1077.
Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE: Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. New England Journal of Medicine 1992, 326: 375–380.
Lee HH, Weis SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, Chu A, Ginzburg HM, Markowitz N, Des Jarlais DC, Blattner WA, Allain JP: Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle Atlantic and central regions of the USA. Journal of Infectious Diseases 1990, 162: 347–352.
Zella D, Mori L, Sala M, Ferrante P, Casoli C, Magnani G, Achilli G, Cattaneo E, Lori F, Bertazzoni U: HTLV-II infection in Italian drug abusers. Lancet 1990, 336: 575–576.
Zazzi M, Romano L, Brasini A, Valensin PE: Low human immunodeficiency virus titer and polymerase chain reaction false-negatives. Journal of Infectious Diseases 1992, 165: 779–780.
Wiktor SZ, Alexander SS, Shaw GM, Weiss SH, Murphy EL, Wilks RJ, Shortly VJ, Handchard B, Blattner WA: Distinguishing between HTLV-I and HTLV-II by Western blot. Lancet 1990, 335: 1533.
Buckner C, Roberts CR, Foung SKH, Lipka J, Reyes GR, Hadlock K, Chan L, Gongora-Biachi RA, Hjelle B, Lal RB: Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations. Journal of Infectious Diseases 1992, 166: 1160–1163.
World Health Organization: WHO criteria to interpret Western blot results in the diagnosis of HIV-1, HIV-2, and HTLV-I/II infections. Weekly Epidemiology Record 1990, 65: 281–288.
Couroucé A, Pillonel J, Lemaire JM, Lemaire JM, Maniez M, Brunet JB: Seroepidemiology of HTLV-I/II infection in universal screening of blood donations in France. AIDS 1993, 7: 841–847.
Brennan M, Runganga J, Barbara JAJ, Contreras M, Tedder RS, Garson JA, Tuke PW, Mortimer PP, McAlpine L, Tosswill JHC: Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. British Medical Journal 1993, 307: 1235–1239.
Soriano V, Calderón E: HTLV-I y transfusiones. Medicina Clínica 1993, 100: 177–178.
Sullivan M, Williams A, Fang C: Transmission of HTLV types I and II by blood transfusion. Archives of Internal Medicine 1991, 151: 2043–2048.
McAlpine L, Parry J, Tosswill J: Evaluation of an EIA for the combined detection of antibodies to HIV-1, HIV-2, HTLV-I and HTLV-II. AIDS 1992, 6: 387–391.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Calderón, E.J., Rey, C., Medrano, F.J. et al. Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain. Eur. J. Clin. Microbiol. Infect. Dis. 14, 686–690 (1995). https://doi.org/10.1007/BF01690875
Issue Date:
DOI: https://doi.org/10.1007/BF01690875